Temporary treatment of hydrocephalus and myelodysplasia with isosorbide: preliminary report.
D001806:Blood Urea Nitrogen; D001835:Body Weight; D002245:Carbon Dioxide / Q000097:blood; D002556:Cerebrospinal Fluid Proteins; D002648:Child; D002986:Clinical Trials as Topic; D005243:Feces; D005663:Furans / Q000627:therapeutic use*; D006257:Head / Q000254:growth & development; D006801:Humans; D006849:Hydrocephalus / Q000150:complications / Q000188:drug therapy*; D007223:Infant; D007231:Infant, Newborn; D007239:Infections / Q000150:complications; D007548:Isosorbide Dinitrate / Q000009:adverse effects; D009566:Nitrates / Q000627:therapeutic use*; D010919:Placebos; D012964:Sodium / Q000097:blood; D013118:Spinal Cord Diseases / Q000188:drug therapy*
D002556:Cerebrospinal Fluid Proteins; D005663:Furans; D009566:Nitrates; D010919:Placebos; D002245:Carbon Dioxide; D012964:Sodium; D007548:Isosorbide Dinitrate